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Informed Consent in Medical Research by Doyal and Tobias is
both a fascinating and frustrating book. Several of the ways in
which it is fascinating relate to the reason the book was written,
the book’s organization, and the wealth of opinion presented. The
frustrations engendered in the reading of the book spring from the
same sources. 
The book was written to highlight, examine, and extend discus-
sion around a single question, ‘Should the BMJ publish reports of
research in which informed consent of the subjects has not been
obtained?’ The question, brought into focus by internal BMJ
debate over whether or not to publish two particular studies (see
Part 2, Chapters 7, 8, and 9), is an important one – not only for the
BMJ but for the world of research publications, in general. That
Richard Smith, BMJ Editor, acknowledges explicitly in the book’s
Foreword that the internal debate, and the decision to produce the
book, resulted from uncertainty and confusion, is to his credit and
to that of the BMJ staff. To suggest that there might be, at this stage
in the evolution of research ethics, universal certitude about
whether there are appropriate conditions under which it would be
ethically acceptable to waive informed consent would be to admit
to a frightening lack of insight about the ethical intricacies of clin-
ical research. Rather, a healthy uncertainty and confusion about
such refined ethical points as consent waivers, and as addressed in
Part 4, Chapter 25, just what does ‘fully’ mean in the term-of-art of
‘fully informed consent’ builds confidence that there is a vigorous
and thoughtful consideration of the wide range of ethical issues
inherent in the publication of biomedical research at the BMJ and
its sister publications. 
The frustration here is that the question never gets answered.
Now, just having applauded the BMJ for publicly wallowing in
their confusions and uncertainties, it may seem odd to suggest that
the book ought to have settled the matter. And I am not suggesting
that the matter can be settled for all time. But one might have
hoped for an epilogue, or the like, indicating whether or not all the
backing and forthing had convinced the BMJ editors and staff that
they should stand by their original decision, or that now, after all
this debate, they ought to set a policy only to publish where
consent has been obtained. This frustration comes from this
author’s perspective as a clinical research ethicist. Unlike the
philosopher whose calling it is to debate indefinitely (and no doubt
the book’s core question, and the innumerable sub-questions it
spawns, could be debated profitably, indefinitely), the clinical ethi-
cist is a practical sort, called on to assist in coming to the most
ethically justifiable solutions at the time solutions need to be
found. But then one can just as easily debate timing, and perhaps
the time to write the BMJ policy has not yet come. 
At the heart of what I am categorizing as the second primary
source of the book’s blessings and curses is all the backing and
forthing. That is, the book has a most interesting yet exhausting
organization. Part 1 starts out straightforwardly enough,
providing the texts of the Nuremberg Code and the Declaration
of Helsinki (albeit the most recent past version of Helsinki, an
obsolescence in a brand new book that ought to give us all pause
about the certitude with which we think we can settle these
ethical issues once and for all). Absolutely riveting is Chapter 2
about the BMJ’s correspondent at the Nuremberg trial, as are all
the Chapters in this first section, with the snippets from
Pappworth and Beecher well placed. Part 2 also opens in a tidy
fashion, presenting the issue(s), the stimulus papers, and then
laying out the debate’s polarities. From there on out, however,
the book becomes a mass of orchestrated chaos. Truly, it is like a
Cage symphony, with every note placed with precision, but
placed in such a way that as each part of the orchestra talks,
another part answers, and then another part pipes up, and then
another cuts in, and on and on to total intellectual exhaustion.
For the research ethics groupie, the organization may be Nirvana.
For the less research ethics sophisticated, it may create a bit of
a blur. But, like any fine symphony, the final movement of the
score brings even the weariest listener back into its grasp. The
book’s editors achieve their grand finale grandly. Part 5’s chap-
ters tie up the work beautifully. 
The final comment about the book’s benefits and burdens is, again,
reminiscent of all the various instruments in the orchestra. The most
striking feature of the book is its richness and breadth. Here, unlike
a Cage symphony that can sound sparsely notated and pared down,
one arrives at the end of the book and feels bathed in the expansive-
ness of Wagnerian opera. The book presents so many voices. 
Great attention was paid to assuring that a wide variety of
persons and perspectives were heard. This is one of the book’s
many joys. But the burden of goals of inclusiveness is that the
attempt is often sisyphean. No matter how many times one pushes
up that rock of diversity, some voices are either not lifted up
or drowned out because of disparities in proportions. Here, the
largest number of voices is professional, whose analyses of the
consent question tend to cluster around consequentially grounded
arguments or come out of duty-based thinking. Few address the
problem from a virtue ethics perspective. If, for example, the
virtue-based arguments had been made more loudly, some of
the authors, who, despite their own best efforts, continue to inap-
propriately conflate the goals of treatment with the goals of
research, might have been shown to be mounting arguments that
do not hold up in the face of even more intensely focused debate.
Additionally, it is interesting to note that in this vast sea of profes-
sional disagreement, the few lay authors (see Kulsum Winship’s
response in Part 2, Chapter 12 and Chapter 28 in Part 4) are consis-
tent in their call for conducting research only with properly
obtained (i.e., parental and/or surrogate included) consent. If more
voices had been heard from those who have been research
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have-consent side, the scales may have tipped. 
As it is, we are left continuing to wallow in the BMJ’s and our
own uncertainties and confusions. And while this may be the best
possible place to be right now, it is uncomfortable. Thus, perhaps
legitimizing our discomforts while supporting and encouraging
further debate and discussion about the need for consent of
subjects in published research reports is, in the end, the greatest
achievement of what is surely, as Richard Smith hoped readers
would conclude, a marvellous book. 
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The names of two of the authors of this paper were published
incorrectly, and should have appeared as follows:
DT Croke (rather than CT Croke)
DR Smith (rather than R Smith)
The publishers wish to apologise for this error.
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